Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page managed by the system. No changes to study content or user-facing details were introduced.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s revision history shows a new revision v3.6.4, replacing the previous v3.6.3; this reflects a small maintenance update to the page documentation.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision label was updated to v3.6.3, replacing the previous v3.6.0. This reflects versioning activity rather than content changes.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now indicates that recruitment has ended and includes new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a revision note (Revision: v3.6.0) and a label adjustment for Intervention/Treatment.SummaryDifference0.3%

- Check78 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a newer revision of the page content.SummaryDifference0.0%

- Check100 days agoChange DetectedResults have been posted for the study, including ORR and PFS metrics with follow-up details and posting/submission dates. The page now shows the study as completed and adds related documents such as the Informed Consent Form and Study Protocol/Statistical Analysis Plan.SummaryDifference2%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.